Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance

✍ Scribed by Csilla Hegedüs; Krisztina Truta-Feles; Géza Antalffy; György Várady; Katalin Német; Csilla Özvegy-Laczka; György Kéri; László Őrfi; Gergely Szakács; Jeffrey Settleman; András Váradi; Balázs Sarkadi

• Book ID: 113489766
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 905 KB
• Volume: 84
• Category: Article
• ISSN: 0006-2952
• DOI: 10.1016/j.bcp.2012.04.010